The news: Half of US pharmaceuticals launched in 2023 underperformed their first-year forecasts, while 39% overperformed, according to an analysis from Trinity Life Sciences.
You've read 0 of 2 free articles this month.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844
1-800-405-0844sales@emarketer.com